ScandiDos ABOSTO:SDOS +6.25%48 ROC (Joel Greenblatt) % is 11.56% as of Apr. 2026. GuruFocus rates OSTO:SDOS with a GF Score™ of 48/100 and a GF Value™ of kr1.14 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 839 Medical Devices & Instruments companies, ScandiDos AB ranks worse than 68.89% on this metric.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. ScandiDos AB's annualized ROC (Joel Greenblatt) % for the quarter that ended in Apr. 2026 was 11.56%.
The historical rank and industry rank for ScandiDos AB's ROC (Joel Greenblatt) % or its related term are showing as below:
OSTO:SDOS'
s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -726.75 Med: -137.45 Max: 8.3
Current: -40.93
During the past 13 years, ScandiDos AB's highest ROC (Joel Greenblatt) % was 8.30%. The lowest was -726.75%. And the median was -137.45%.
OSTO:SDOS's ROC (Joel Greenblatt) % is ranked worse than 68.89% of 839
companies
in the Medical Devices & Instruments industry
Industry Median: 3.94
vs OSTO:SDOS: -40.93
ScandiDos AB's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was 0.00% per year.
ScandiDos AB (OSTO:SDOS) ROC (Joel Greenblatt) % Explanation
The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.
ScandiDos AB ROC (Joel Greenblatt) % Related Terms
ScandiDos AB ROC (Joel Greenblatt) % Historical Data
* Premium members only.
The historical data trend for ScandiDos AB's ROC (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSTO:SDOS vs ABT, SYK, MDT: ROC (Joel Greenblatt) % Comparison
For the Medical Devices subindustry, ScandiDos AB's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ScandiDos AB ROC (Joel Greenblatt) % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, ScandiDos AB's ROC (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where ScandiDos AB's ROC (Joel Greenblatt) % falls into.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:
EBIT stands for Earnings Before Interest and Taxes.
Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.
GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.
Note:
The EBIT data used here is four times the quarterly (Apr. 2026) EBIT data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROC (Joel Greenblatt) % of 11.56% mean?
ScandiDos AB (OSTO:SDOS) has a ROC (Joel Greenblatt) % of 11.56% as of Apr. 2026. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on ScandiDos AB and its competitors. According to the industry distribution chart, ScandiDos AB ranks #578 out of 839 companies in the Medical Devices & Instruments industry, placing it in the top 68.9%.
Is ScandiDos AB's ROC (Joel Greenblatt) % too high?
ScandiDos AB's current ROC (Joel Greenblatt) % is 11.56%. The Medical Devices & Instruments industry median ROC (Joel Greenblatt) % is 3.94. ScandiDos AB's value of 11.56% is 193.4% above this industry median. Based on the distribution chart, ScandiDos AB ranks #578 out of 839 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, ScandiDos AB has a GF Score™ of 48/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does ScandiDos AB's ROC (Joel Greenblatt) % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, ScandiDos AB ranks #578 out of 839 companies for ROC (Joel Greenblatt) %. This places ScandiDos AB in the lower half of its industry. The industry median ROC (Joel Greenblatt) % is 3.94. ScandiDos AB's value of 11.56% is 193.4% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Medical Devices & Instruments company?
The median ROC (Joel Greenblatt) % among Medical Devices & Instruments companies is 3.94, based on 839 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. ScandiDos AB's current ROC (Joel Greenblatt) % of 11.56% is 193.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on ScandiDos AB and its competitors. For the Medical Devices & Instruments industry, the median ROC (Joel Greenblatt) % is 3.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ScandiDos AB's current ROC (Joel Greenblatt) % is 11.56%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ScandiDos AB stock overvalued right now?
Based on GuruFocus' analysis, ScandiDos AB (OSTO:SDOS) is currently considered Modestly Undervalued. The stock's GF Value™ is kr1.14, compared to a current price of kr0.85 — trading 25.4% below its estimated fair value. The current ROC (Joel Greenblatt) % is 11.56% and 193.4% above the Medical Devices & Instruments industry median of 3.94. ScandiDos AB's overall GF Score™ is 48/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For ScandiDos AB (OSTO:SDOS), the current ROC (Joel Greenblatt) % is 11.56% as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is ScandiDos AB (OSTO:SDOS) Overvalued in 2026?
Based on GuruFocus' analysis, ScandiDos AB stock appears to be undervalued.
The current stock price of kr0.85 is trading 25.4% below its estimated GF Value™ of kr1.14.
GuruFocus considers ScandiDos AB to be Modestly Undervalued.
Key valuation signals for OSTO:SDOS:
ROC (Joel Greenblatt) %: 11.56%
GF Value™: kr1.14 vs. price of kr0.85 (25.4% below fair value)
Industry Position: 193.4% above the Medical Devices & Instruments median (#578 of 839)
No single metric tells the full story. See the OSTO:SDOS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
ScandiDos AB is engaged in providing radiation therapy for cancer. Its product, Delta4 Phantom+, and its various hardware and software options are at the heart of everything ScandiDos does, from product development and production to marketing, sales, and customer support. With Delta4 HexaMotion ScandiDos has successfully developed a motion platform that recreates the movement of the tumor in six dimensions and independently simulates the patient's breathing movement.
48GF Score
Get the complete analysis for OSTO:SDOS
ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:SDOS has been successfully added to your 
